Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Clinical diagnosis and treatment of alpha-fetoprotein-negative small hepatic lesions.

Xu Y, Lu X, Mao Y, Sang X, Zhao H, Du S, Xu H, Sun Y, Yang H, Chi T, Yang Z, Zhong S, Huang J.

Chin J Cancer Res. 2013 Aug;25(4):382-8. doi: 10.3978/j.issn.1000-9604.2013.08.12.

2.

Contrast ultrasound in hepatocellular carcinoma at a tertiary liver center: First Indian experience.

Laroia ST, Bawa SS, Jain D, Mukund A, Sarin S.

World J Radiol. 2013 Jun 28;5(6):229-40. doi: 10.4329/wjr.v5.i6.229.

3.
4.

Use of 18F-FDG PET Scan and Ultrasound-guided Biopsy in the Diagnosis of Hepatic Carcinomas.

Shao H, Cheng W, Yu L, Li Y, Jing H.

Hepatogastroenterology. 2015 Jun;62(140):978-81.

PMID:
26902040
6.

Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.

Egger C, Goertz RS, Strobel D, Lell M, Neurath MF, Knieling F, Scharf M.

Ultraschall Med. 2012 Dec;33(6):587-92. doi: 10.1055/s-0032-1325545. Epub 2012 Nov 15.

PMID:
23154871
7.
8.

C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.

Li JJ, Zheng JS, Cui SC, Cui XW, Hu CX, Fang D, Ye LC.

World J Gastroenterol. 2015 Mar 14;21(10):3035-40. doi: 10.3748/wjg.v21.i10.3035.

9.

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, Brú C, Bruix J.

Hepatology. 2008 Jan;47(1):97-104. Erratum in: Hepatology. 2008 Feb;47(2):769.

PMID:
18069697
10.

Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography.

D'Onofrio M, Rozzanigo U, Masinielli BM, Caffarri S, Zogno A, Malagò R, Procacci C.

J Clin Ultrasound. 2005 May;33(4):164-72.

PMID:
15856516
11.

Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.

Tarantino L, Ambrosino P, Di Minno MN.

World J Gastroenterol. 2015 Aug 28;21(32):9457-60. doi: 10.3748/wjg.v21.i32.9457. Review.

12.

Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver.

Quaia E, De Paoli L, Angileri R, Cabibbo B, Cova MA.

Eur J Radiol. 2014 Mar;83(3):456-62. doi: 10.1016/j.ejrad.2013.12.012. Epub 2013 Dec 16.

PMID:
24387826
13.

Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.

Rennert J, Georgieva M, Schreyer AG, Jung W, Ross C, Stroszczynski C, Jung EM.

Clin Hemorheol Microcirc. 2011;49(1-4):67-81. doi: 10.3233/CH-2011-1458.

PMID:
22214679
14.

Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.

Armbruster M, Sourbron S, Haug A, Zech CJ, Ingrisch M, Auernhammer CJ, Nikolaou K, Paprottka PM, Rist C, Reiser MF, Sommer WH.

Invest Radiol. 2014 Jan;49(1):7-14. doi: 10.1097/RLI.0b013e3182a4eb4a.

PMID:
24002080
15.

New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.

Jung EM, Schreyer AG, Schacherer D, Menzel C, Farkas S, Loss M, Feuerbach S, Zorger N, Fellner C.

Clin Hemorheol Microcirc. 2009;43(1-2):57-69. doi: 10.3233/CH-2009-1221.

PMID:
19713601
16.

Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.

Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI.

Invest Radiol. 2010 Feb;45(2):96-103. doi: 10.1097/RLI.0b013e3181c5faf7.

PMID:
20057319
17.

[Staging of hepatocellular carcinoma. Comparison of ultrasonography, computerized tomography, magnetic resonance, digital angiography, and computerized tomography with lipiodol].

Bartolozzi C, Lencioni R, Caramella D, Gibilisco G, Cioni R, Vignali C.

Radiol Med. 1994 Oct;88(4):429-36. Italian.

PMID:
7997616
18.

Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).

Strobel D, Seitz K, Blank W, Schuler A, Dietrich CF, von Herbay A, Friedrich-Rust M, Bernatik T.

Ultraschall Med. 2009 Aug;30(4):376-82. doi: 10.1055/s-0028-1109672. Epub 2009 Aug 17.

PMID:
19688669
19.
20.

[The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (<or=3 cm) detection].

Xu PJ, Yan FH, Wang JH, Lin J, Ji Y, Chen CZ, Shen JZ, Li RC.

Zhonghua Yi Xue Za Zhi. 2009 Mar 10;89(9):592-6. Chinese.

PMID:
19595157

Supplemental Content

Support Center